Changeflow GovPing Pharma & Drug Safety HSK44459 Phase III IPF trial by Haisco
Routine Notice Added

HSK44459 Phase III IPF trial by Haisco

Favicon for clinicaltrials.gov ClinicalTrials.gov
Detected
Email

Summary

HSK44459 Phase III IPF trial by Haisco

Archived snapshot

Apr 10, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Show glossary

Get daily alerts for ClinicalTrials.gov

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from GP.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
GP
Instrument
Notice

Get alerts for this source

We'll email you when ClinicalTrials.gov publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!